SURPASS

(1% diclofenac sodium)

Prescription-strength SURPASS offers veterinarians a simple, unique topical delivery that horse owners can apply themselves.

  • The only FDA-approved topical application in horses for the control of pain and inflammation associated with osteoarthritis (OA) in hock, knee, fetlock, and pastern joints in horses.
  • SURPASS topical cream is white to pinkish-white and is packaged in 124 gram trilaminate tubes.

For topical use in horses only. Wear gloves to prevent absorption into the hands. Direct contact with the skin should be avoided. If contact occurs, the skin should be washed immediately with soap and water.

Treatment with SURPASS cream should be terminated if signs such as inappetence, colic, fecal abnormalities, anemia or depression are observed.

The systemic effects of excess diclofenac doses that exceed the recommented label amount and duration have not been evaluated. The safetly of SURPASS cream has not been investigated in breeding, pregnant or lactating horses, or in horses under one year of age. Please consult the label for full product information.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Apply a five-inch (5”) ribbon of SURPASS topical cream twice daily over the affected joint for up to 10 days.

  • Ease of application maximizes client compliance.
  • SURPASS is a unique topical NSAID that provides pain relief directly at the site of inflammation.1,2
  • The unique WISDOM liposomal delivery technology of SURPASS helps enhance local absorption of the active ingredient at the site of inflammation.2,3

References

1. SURPASS (1% diclofenac sodium) [Freedom of Information Summary]. Greensboro, NC: IDEXX Pharmaceuticals, Inc.; 2004.

2. Caldwell FJ, Mueller PO, Lynn RC, Budsberg SC. Effect of topical application of diclofenac liposomal suspension on experimentally induced subcutaneous inflammation in horses. Am J Vet Res. 2004;65(3):271–276.

3. Frisbie DD, McIlwraith CW, Kawcak CE, Werpy NM, Pearce GL. Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis. Am J Vet Res. 2009;70(2):210–215.

Product Resources

Technical Assistance

  • Boehringer Ingelheim Vetmedica, Inc.

    Equine Division

    3902 Gene Field Road
    St. Joseph, Missouri 64506

    • Phone 866-638-2226
    • Fax 816-676-4326